These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Hepatocyte growth factor and sonic Hedgehog expression in cerebellar neural progenitor cells costimulate medulloblastoma initiation and growth. Binning MJ; Niazi T; Pedone CA; Lal B; Eberhart CG; Kim KJ; Laterra J; Fults DW Cancer Res; 2008 Oct; 68(19):7838-45. PubMed ID: 18829539 [TBL] [Abstract][Full Text] [Related]
3. Expression of GNAS, TP53, and PTEN Improves the Patient Prognostication in Sonic Hedgehog (SHH) Medulloblastoma Subgroup. da Silva LS; Mançano BM; de Paula FE; Dos Reis MB; de Almeida GC; Matsushita M; Junior CA; Evangelista AF; Saggioro F; Serafini LN; Stavale JN; Malheiros SMF; Lima M; Hajj GNM; de Lima MA; Taylor MD; Leal LF; Reis RM J Mol Diagn; 2020 Jul; 22(7):957-966. PubMed ID: 32380172 [TBL] [Abstract][Full Text] [Related]
4. The miR-17/92 polycistron is up-regulated in sonic hedgehog-driven medulloblastomas and induced by N-myc in sonic hedgehog-treated cerebellar neural precursors. Northcott PA; Fernandez-L A; Hagan JP; Ellison DW; Grajkowska W; Gillespie Y; Grundy R; Van Meter T; Rutka JT; Croce CM; Kenney AM; Taylor MD Cancer Res; 2009 Apr; 69(8):3249-55. PubMed ID: 19351822 [TBL] [Abstract][Full Text] [Related]
5. Novel molecular subgroups for clinical classification and outcome prediction in childhood medulloblastoma: a cohort study. Schwalbe EC; Lindsey JC; Nakjang S; Crosier S; Smith AJ; Hicks D; Rafiee G; Hill RM; Iliasova A; Stone T; Pizer B; Michalski A; Joshi A; Wharton SB; Jacques TS; Bailey S; Williamson D; Clifford SC Lancet Oncol; 2017 Jul; 18(7):958-971. PubMed ID: 28545823 [TBL] [Abstract][Full Text] [Related]
6. Apoptosis suppression by somatic cell transfer of Bcl-2 promotes Sonic hedgehog-dependent medulloblastoma formation in mice. McCall TD; Pedone CA; Fults DW Cancer Res; 2007 Jun; 67(11):5179-85. PubMed ID: 17545597 [TBL] [Abstract][Full Text] [Related]
7. SMARCA4/Brg1 coordinates genetic and epigenetic networks underlying Shh-type medulloblastoma development. Shi X; Wang Q; Gu J; Xuan Z; Wu JI Oncogene; 2016 Nov; 35(44):5746-5758. PubMed ID: 27065321 [TBL] [Abstract][Full Text] [Related]
8. YB-1 is elevated in medulloblastoma and drives proliferation in Sonic hedgehog-dependent cerebellar granule neuron progenitor cells and medulloblastoma cells. Dey A; Robitaille M; Remke M; Maier C; Malhotra A; Gregorieff A; Wrana JL; Taylor MD; Angers S; Kenney AM Oncogene; 2016 Aug; 35(32):4256-68. PubMed ID: 26725322 [TBL] [Abstract][Full Text] [Related]
9. Identification of a neuronal transcription factor network involved in medulloblastoma development. Lastowska M; Al-Afghani H; Al-Balool HH; Sheth H; Mercer E; Coxhead JM; Redfern CP; Peters H; Burt AD; Santibanez-Koref M; Bacon CM; Chesler L; Rust AG; Adams DJ; Williamson D; Clifford SC; Jackson MS Acta Neuropathol Commun; 2013 Jul; 1():35. PubMed ID: 24252690 [TBL] [Abstract][Full Text] [Related]
10. RNF220 is required for cerebellum development and regulates medulloblastoma progression through epigenetic modulation of Shh signaling. Ma P; An T; Zhu L; Zhang L; Wang H; Ren B; Sun B; Zhou X; Li Y; Mao B Development; 2020 Jun; 147(21):. PubMed ID: 32376680 [TBL] [Abstract][Full Text] [Related]
11. A Novel Method for Rapid Molecular Subgrouping of Medulloblastoma. Gómez S; Garrido-Garcia A; Garcia-Gerique L; Lemos I; Suñol M; de Torres C; Kulis M; Pérez-Jaume S; Carcaboso ÁM; Luu B; Kieran MW; Jabado N; Kozlenkov A; Dracheva S; Ramaswamy V; Hovestadt V; Johann P; Jones DTW; Pfister SM; Morales La Madrid A; Cruz O; Taylor MD; Martin-Subero JI; Mora J; Lavarino C Clin Cancer Res; 2018 Mar; 24(6):1355-1363. PubMed ID: 29351917 [No Abstract] [Full Text] [Related]
12. Serpine2/PN-1 Is Required for Proliferative Expansion of Pre-Neoplastic Lesions and Malignant Progression to Medulloblastoma. Vaillant C; Valdivieso P; Nuciforo S; Kool M; Schwarzentruber-Schauerte A; Méreau H; Cabuy E; Lobrinus JA; Pfister S; Zuniga A; Frank S; Zeller R PLoS One; 2015; 10(4):e0124870. PubMed ID: 25901736 [TBL] [Abstract][Full Text] [Related]
13. BarTeL, a Genetically Versatile, Bioluminescent and Granule Neuron Precursor-Targeted Mouse Model for Medulloblastoma. Shackleford GM; Shi XH; Swanson KS; Mahdi MY; Gonzalez-Gomez I; Asgharzadeh S; D'Apuzzo M; Erdreich-Epstein A; Moats RA PLoS One; 2016; 11(6):e0156907. PubMed ID: 27310018 [TBL] [Abstract][Full Text] [Related]
14. Sonic hedgehog-induced histone deacetylase activation is required for cerebellar granule precursor hyperplasia in medulloblastoma. Lee SJ; Lindsey S; Graves B; Yoo S; Olson JM; Langhans SA PLoS One; 2013; 8(8):e71455. PubMed ID: 23951168 [TBL] [Abstract][Full Text] [Related]
15. Sequential activation of Snail1 and N-Myc modulates sonic hedgehog-induced transformation of neural cells. Colvin Wanshura LE; Galvin KE; Ye H; Fernandez-Zapico ME; Wetmore C Cancer Res; 2011 Aug; 71(15):5336-45. PubMed ID: 21646478 [TBL] [Abstract][Full Text] [Related]
16. Prognostic effect of whole chromosomal aberration signatures in standard-risk, non-WNT/non-SHH medulloblastoma: a retrospective, molecular analysis of the HIT-SIOP PNET 4 trial. Goschzik T; Schwalbe EC; Hicks D; Smith A; Zur Muehlen A; Figarella-Branger D; Doz F; Rutkowski S; Lannering B; Pietsch T; Clifford SC Lancet Oncol; 2018 Dec; 19(12):1602-1616. PubMed ID: 30392813 [TBL] [Abstract][Full Text] [Related]
17. YAP1 is amplified and up-regulated in hedgehog-associated medulloblastomas and mediates Sonic hedgehog-driven neural precursor proliferation. Fernandez-L A; Northcott PA; Dalton J; Fraga C; Ellison D; Angers S; Taylor MD; Kenney AM Genes Dev; 2009 Dec; 23(23):2729-41. PubMed ID: 19952108 [TBL] [Abstract][Full Text] [Related]
19. N-myc can substitute for insulin-like growth factor signaling in a mouse model of sonic hedgehog-induced medulloblastoma. Browd SR; Kenney AM; Gottfried ON; Yoon JW; Walterhouse D; Pedone CA; Fults DW Cancer Res; 2006 Mar; 66(5):2666-72. PubMed ID: 16510586 [TBL] [Abstract][Full Text] [Related]
20. Subgroup-specific prognostic implications of TP53 mutation in medulloblastoma. Zhukova N; Ramaswamy V; Remke M; Pfaff E; Shih DJ; Martin DC; Castelo-Branco P; Baskin B; Ray PN; Bouffet E; von Bueren AO; Jones DT; Northcott PA; Kool M; Sturm D; Pugh TJ; Pomeroy SL; Cho YJ; Pietsch T; Gessi M; Rutkowski S; Bognar L; Klekner A; Cho BK; Kim SK; Wang KC; Eberhart CG; Fevre-Montange M; Fouladi M; French PJ; Kros M; Grajkowska WA; Gupta N; Weiss WA; Hauser P; Jabado N; Jouvet A; Jung S; Kumabe T; Lach B; Leonard JR; Rubin JB; Liau LM; Massimi L; Pollack IF; Shin Ra Y; Van Meir EG; Zitterbart K; Schüller U; Hill RM; Lindsey JC; Schwalbe EC; Bailey S; Ellison DW; Hawkins C; Malkin D; Clifford SC; Korshunov A; Pfister S; Taylor MD; Tabori U J Clin Oncol; 2013 Aug; 31(23):2927-35. PubMed ID: 23835706 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]